BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:53:00 PM | Browse: 1210 | Download: 1173
 |
Received |
|
2013-02-25 19:38 |
 |
Peer-Review Started |
|
2013-02-26 15:18 |
 |
To Make the First Decision |
|
2013-03-18 15:44 |
 |
Return for Revision |
|
2013-03-20 08:18 |
 |
Revised |
|
2013-03-26 17:22 |
 |
Second Decision |
|
2013-06-06 09:21 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-06-06 12:59 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-08-09 09:58 |
 |
Publish the Manuscript Online |
|
2013-08-27 16:46 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Case Report |
Article Title |
Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Cristian Cerda, Miguel Bruguera and Albert Parés |
Funding Agency and Grant Number |
|
Corresponding Author |
Miguel Bruguera, Professor, Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clínic, Villarroel 270, 08036 Barcelona, Spain. bruguera@clinic.ub.es |
Key Words |
Toxic hepatitis; Hepatotoxicity; Glucosamine; Chondroitin sulphate; Osteoarthritis |
Core Tip |
A questionnaire was given to 151 consecutive patients with chronic liver disease of different etiology (mean age 59 years, 56.9% women) attended in an outpatient clinic with the aim of evaluating the frequency of consumption of these drugs and determine whether their use coincided with a worsening in liver function test results. Twenty-three patients (15.2%) recognized having taken products containing glucosamine or chondroitin sulfate previously or at the time of the questionnaire. |
Publish Date |
2013-08-27 16:46 |
Citation |
Cerda C, Bruguera M, Parés A. Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease. World J Gastroenterol 2013; 19(32): 5381-5384 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i32/5381.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i32.5381 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345